Nila | $2,400,000 | (Oct 17, 2025)
Upciti | $20,000,000 | (Oct 17, 2025)
MGT Insurance | $21,600,000 | (Oct 17, 2025)
Certified by Founder
Lodge
Corsair Pharma
start up
United States
- Sunnyvale, California
- 22/09/2023
- Series B
- $23,000,000
Corsair Pharma is developing transformative solutions to improve the therapeutic profile of medications and provide superior treatment options for patients. The company is focused on the development of novel prodrugs of treprostinil to treat patients with PAH using a once-daily transdermal patch.
- Industry Pharmaceutical Manufacturing
- Website https://www.corsairpharma.com/
- LinkedIn https://www.linkedin.com/company/corsairpharma/about/
Sonic Fire Tech | $3,500,000 | (Oct 17, 2025)
Strella | $14,000,000 | (Oct 17, 2025)
Temple Digital Group | $5,000,000 | (Oct 17, 2025)
ATDev | $3,000,000 | (Oct 17, 2025)
Jack and Jill | $20,000,000 | (Oct 17, 2025)
Brook Health | $28,000,000 | (Oct 17, 2025)
Vega Health | $4,000,000 | (Oct 17, 2025)
ExaCare AI | $30,000,000 | (Oct 17, 2025)
Daylight(US) | $75,000,000 | (Oct 17, 2025)